Precision Business Insights has published a report on the global lung cancer therapeutics market, estimating its value at USD 36.7 Billion in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 10.4% over the forecast period 2026-2032. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of...

Precision Business Insights has published a report on the global lung cancer therapeutics market, estimating its value at USD 36.7 Billion in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 10.4% over the forecast period 2026-2032. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of...

Precision Business Insights has published a report on the global pancreatic cancer therapeutics market, estimating its value at USD 5,848.2 Million in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% over the forecast period 2026-2032. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed...

Precision Business Insights has published a report on the global Prostate Cancer Therapeutics Market, estimating its value at USD 12,154.0 billion in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 8.7% over the forecast period 2026-2032. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed...

Increasing awareness campaigns about cancer prevention and treatment are encouraging patients to seek medical help earlier. Early detection significantly improves treatment success rates. This growing awareness is indirectly supporting the demand for anti-cancer drugs. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...

Europe is also contributing significantly to market expansion with strong support for biotechnology research and innovation. Government funding and collaborations with universities are accelerating drug development. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering a strong CAGR of...